From Suspicion to First Dose: Pharmacist Strategies to Close the ATTR-CM Treatment Gap

Meeting Objectives:

• • Identify barriers leading to increased time from suspicion to treatment for patients with ATTR-CM.
  • Describe how pharmacists can lead coordinated, sustainable ATTR-CM identification.
  • Discuss strategies to integrate ATTR-CM identification into existing procedural and heart failure care workflows.